Position in NVO
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$11,638,681
+$2,994,016 QoQ
Shares Held
242,776
+3.2% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
3.03%
of 13F equity value
Holder Rank
#144
of 1,348 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Knuff & Co LLC holds $24,047,308 across 10 Drug Manufacturers - General names. NVO ranks #1 (48.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVO |
Novo Nordisk A S
This page
|
242,776 | $11,638,681 | |
| 2 | JNJ |
Johnson & Johnson
|
10,973 | $2,786,812 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
17,641 | $2,228,763 | |
| 4 | ABBV |
AbbVie Inc.
|
8,555 | $2,152,780 | |
| 5 | MRK |
Merck & Co., Inc.
|
13,038 | $1,675,383 | |
| 6 | PFE |
Pfizer Inc
|
63,859 | $1,537,724 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
16,438 | $947,157 | |
| 8 | AMGN |
Amgen Inc
|
1,800 | $651,816 |
All Filings in NVO
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,638,681 | 242,776 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $8,644,665 | 235,229 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $8,738,640 | 171,750 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $14,151,281 | 255,024 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $8,828,969 | 127,919 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $5,823,655 | 83,866 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,296,665 | 15,074 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $847,897 | 7,121 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $452,057 | 3,167 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $8,346 | 65 | Shares | Sole | 2024-05-09 | |
| No filing history on record for this holder in this stock. | ||||||